Franklin Resources’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-611,722
Closed -$106M 1675
2015
Q1
$106M Sell
611,722
-15,550
-2% -$2.28M 0.05% 376
2014
Q4
$72.1M Buy
627,272
+95,102
+18% +$11.5M 0.03% 476
2014
Q3
$83.1M Buy
532,170
+248,400
+88% +$36M 0.04% 426
2014
Q2
$35M Sell
283,770
-347,034
-55% -$38.4M 0.02% 718
2014
Q1
$65.4M Sell
630,804
-388,740
-38% -$39.8M 0.03% 495
2013
Q4
$91.7M Sell
1,019,544
-204,036
-17% -$16.3M 0.04% 390
2013
Q3
$81.8M Sell
1,223,580
-289,286
-19% -$19.9M 0.04% 407
2013
Q2
$100M Buy
+1,512,866
New +$86.5M 0.06% 325

Other funds holding SLXP

Franklin Resources's SLXP Position: Q2 2015 in Review

Franklin Resources sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 611,722 shares — an estimated $106M sold.

Franklin Resources first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $106M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Franklin Resources reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Franklin Resources sold 611,722 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $106M.
  • Franklin Resources first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Franklin Resources's SALIX PHARMACEUTICALS LTD DEL position peaked at $106M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Franklin Resources's 13F filing for Q2 2015, filed 12 Aug 2015.